3-(Boc-amino)-3-methylazetidine - CAS 1018443-01-0
Catalog: |
BB000668 |
Product Name: |
3-(Boc-amino)-3-methylazetidine |
CAS: |
1018443-01-0 |
Synonyms: |
N-(3-methyl-3-azetidinyl)carbamic acid tert-butyl ester; tert-butyl N-(3-methylazetidin-3-yl)carbamate |
IUPAC Name: | tert-butyl N-(3-methylazetidin-3-yl)carbamate |
Description: | 3-(Boc-amino)-3-methylazetidine (CAS# 1018443-01-0 ) is a useful research chemical. |
Molecular Weight: | 186.25 |
Molecular Formula: | C9H18N2O2 |
Canonical SMILES: | CC1(CNC1)NC(=O)OC(C)(C)C |
InChI: | InChI=1S/C9H18N2O2/c1-8(2,3)13-7(12)11-9(4)5-10-6-9/h10H,5-6H2,1-4H3,(H,11,12) |
InChI Key: | BFHSUIWEPMCBQR-UHFFFAOYSA-N |
Storage: | Sealed in dry, 2-8 °C |
LogP: | 1.40620 |
Publication Number | Title | Priority Date |
WO-2021105072-A1 | 1,8-naphthyridin-2-one compounds for the treatment of autoimmune disease | 20191126 |
WO-2021099406-A1 | Spiro(isobenzofuranazetidine) compounds for the treatment of autoimmune disease | 20191120 |
WO-2021099284-A1 | Hydro-1h-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune disease | 20191119 |
WO-2020207991-A1 | Hexahydro-1h-pyrazino[1,2-a]pyrazine compounds for the treatment of autoimmune disease | 20190409 |
TW-202104230-A | Hexahydro-1h-pyrazino[1,2-a]pyrazine compounds for the treatment of autoimmune disease | 20190409 |
Complexity: | 204 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 186.136827821 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 186.136827821 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 50.4 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Azetidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS